Used in pharmaceutical research as a key intermediate in the synthesis of folate receptor-targeted drugs, particularly in the development of anticancer agents. Its structure allows for selective binding to folate receptors, which are overexpressed in many cancer cells, making it valuable in targeted therapy. Also employed in the preparation of radiolabeled compounds for imaging and diagnostics. Commonly modified to enhance solubility and bioavailability in drug formulations.